, "Eleven Comprehensive Cancer Care Units will be built up within a...
Category:
Health
Latest
Uttar Pradesh gives financial approval for Ayushman Bharat- PM Jan Arogya Yojana
The state government has given financial approval for the...
Tele-MANAS helpline received over 2 lakh calls since launch in Oct 2022
More than 1,900 counsellors have been trained and they are running...
Indian pharma market expected to hit USD 130 billion by 2030: Sadananda Gowda
“India has been serving more than 200 countries with its pharma products and will continue to discharge its responsibilities. We intend to continue formulating plans that are based on sound science, technology, business sense, and ethics,” Gowda said.
Pharmaceuticals are one of the top-10 attractive sectors for foreign investment in India. FDI inflows in the pharmaceuticals sector reached Rs 3,650 crore in 2019-20, recording a growth of 98 per cent year-on-year, he added.
Number of newborns in China drops 15% in 2020 as coronavirus weighs
China saw 10.035 million births last year, the ministry said on Monday, compared with 11.79 million in 2019. Of those born last year, 52.7% were boys and 47.3% girls.
In recent years, many couples have been reluctant to have children due to the rising cost of health care, education and housing. The abandoning of the decades-long one-child policy in 2016 has not provided much impetus to the country’s birth rate.
No provision of insurance for recipients of COVID-19 vaccine: Choubey
The COVID-19 vaccination is entirely voluntary for the beneficiary, Minister of State for Health Ashwini Choubey said in response to a question on whether those administered/to be administered with the COVID-19 vaccines are insured against any kind of side effects or medical complications that may arise due to inoculation.
Overall COVID-19 seropositivity among healthcare workers over 25 per cent: minister
The Indian Council of Medical Research is undertaking periodic sero-surveillance to monitor the trend of COVID-19 infection. As per the third seroprevalence study (December 2020 to January 2021) results the overall COVID-19 seropositivity among healthcare workers is assessed to be 25.7 per cent,” he said in a written reply. Seroprevalence is highest among doctors and nurses (26.6 per cent), followed by para-medical staff (25.4 per cent), field staff (25.3 per cent) and administrative staff (24.9 per cent), Choubey said in a written reply.
WHO says coronavirus unlikely to have leaked from China lab
The WHO team’s mission is intended to be an initial step delving into the origins of the virus, which is believed to have originated in bats before being passed to humans through another species of wild animal, such as a pangolin or bamboo rat, which is considered an exotic delicacy by some in China.
Transmission through the trade in frozen products was also a possibility, WHO food safety and animal diseases expert Peter Ben Embarek said.
Indian army drills dog squad to sniff out COVID-19
Several countries are considering using dogs to identify the coronavirus at airports and other public spaces. But the military deployment is the first time in India that dogs are being used to detect COVID-19, said Colonel Surender Saini, an army dog trainer.
India backs AstraZeneca shot despite South Africa halt
Paul said Johnson & Johnson could manufacture its shot in India. He also said many more vaccines, including Russia’s Sputnik V, Cadila Healthcare’s ZyCov-D and a Novavax product, were in the queue.
EU antitrust regulators halt Aon, Willis probe, await data
The European Commission, which kicked off its probe in December because of concerns the deal to create the world’s largest insurance broker may hurt competition in major markets, said it stopped the clock on Monday.
“This procedure in merger investigations is activated if the parties fail to provide, in a timely fashion, an important piece of information that the Commission has requested from them,” a spokeswoman for the EU competition enforcer said.
A few Covid vaccine recipients developed a rare blood disorder
It is not known whether this blood disorder is related to the Covid vaccines.
More than 31 million people in the United States have received at least one dose, and 36 similar cases had been reported to the government’s Vaccine Adverse Event Reporting System, VAERS, by the end of January. The cases involved either the Pfizer-BioNTech or Moderna vaccine, the only two authorized so far for emergency use in the United States.
Astrazeneca gets nod to use ant-diabetes drug for kidney disease in India
“Despite currently available therapies, a significant unmet need for effective management of CKD continues to exist globally. With the approval of dapagliflozin for CKD in India, an already effective type-2 diabetes and select heart failure treatment, can now be used by nephrologists in the management of CKD,” AstraZeneca India Vice President – Medical Affairs and Regulatory Anil Kukreja said.